{"nct_id":"NCT06369285","title":"A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer","status":"RECRUITING","status_verified_date":"2025-07","start_date":"2024-11-19","start_date_type":"ACTUAL","primary_completion_date":"2027-06-30","primary_completion_date_type":"ESTIMATED","completion_date":"2028-12-31","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["PBYI"]}